Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nephros Inc (NEPH)

Nephros Inc (NEPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,324
  • Shares Outstanding, K 9,007
  • Annual Sales, $ 10,330 K
  • Annual Income, $ -3,420 K
  • 60-Month Beta 1.29
  • Price/Sales 6.41
  • Price/Cash Flow N/A
  • Price/Book 4.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.50 +15.23%
on 07/08/20
8.79 -14.79%
on 06/29/20
-0.49 (-6.14%)
since 06/12/20
3-Month
6.50 +15.23%
on 07/08/20
10.00 -25.10%
on 05/06/20
+0.10 (+1.42%)
since 04/14/20
52-Week
4.42 +69.46%
on 03/18/20
11.35 -34.01%
on 10/18/19
+1.62 (+27.60%)
since 07/12/19

Most Recent Stories

More News
Nephros to Present at Zooming with LD

via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial...

NEPH : 7.49 (+0.20%)
Nephros Announces Preliminary Financial Results for Second Quarter 2020

Anticipates $1.6 Million Net Revenues

NEPH : 7.49 (+0.20%)
Nephros Set to Join Russell Microcap(R) Index

via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial...

NEPH : 7.49 (+0.20%)
Nephros to Present at the Virtual Summer Summit

via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial...

NEPH : 7.49 (+0.20%)
Nephros, Inc. to Hold Virtual Annual Meeting of Stockholders

EQNX::TICKER_START (NASDAQ:NEPH), EQNX::TICKER_END

NEPH : 7.49 (+0.20%)
Nephros Reports First Quarter Financial Results

Product Revenue up 43% over Q1 2019

NEPH : 7.49 (+0.20%)
Nephros Announces First Quarter 2020 Financial Results Conference Call

via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial...

NEPH : 7.49 (+0.20%)
Chembio (CEMI) Jumps: Stock Rises 7.1%

Chembio (CEMI) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

CEMI : 5.46 (+17.42%)
NEPH : 7.49 (+0.20%)
Nephros Sees Hammer Chart Pattern: Time to Buy?

Nephros has been struggling lately, but the selling pressure may be coming to an end soon.

NEPH : 7.49 (+0.20%)
OraSure Technologies (OSUR) in Focus: Stock Moves 7.6% Higher

OraSure Technologies (OSUR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

OSUR : 14.01 (+0.29%)
NEPH : 7.49 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NEPH with:

Business Summary

Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider.

See More

Key Turning Points

2nd Resistance Point 7.75
1st Resistance Point 7.62
Last Price 7.49
1st Support Level 7.23
2nd Support Level 6.97

See More

52-Week High 11.35
Fibonacci 61.8% 8.70
Fibonacci 50% 7.89
Last Price 7.49
Fibonacci 38.2% 7.07
52-Week Low 4.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar